Paragon Ventures

Overview

Paragon Ventures is a specialized investment banking firm providing M&A advisory services exclusively to mid-market healthcare and life sciences companies. Founded in 1994, the firm has completed 350+ transactions across healthcare subsectors including specialty pharmacy, pharmacy distribution, home infusion, HME/DME, and home health. Paragon primarily represents sellers, leveraging a proprietary process and a network of 6,000+ buyers and investors to maximize shareholder value.

Services

• Sell-Side M&A — Full-scope advisory for healthcare business owners seeking to sell, including buyer identification, competitive process management, and deal negotiation
• Divestitures — Carve-out advisory for companies divesting non-core healthcare assets
• Valuations — Pre-market and transaction-ready business valuations for planning and negotiation
• Exit Strategy — Multi-year planning for owners preparing for eventual sale or succession

Competitive Position

Paragon’s 30+ years of healthcare-only focus and 350+ transaction track record create deep sector expertise that generalist investment banks cannot match. The firm’s principals are former healthcare business operators, giving them credibility with owner-founders who value advisors who understand the complexities of pharmacy and healthcare services businesses. Recent activity includes advising on The Charles Pharmacy sale to Strive Medical (February 2025) and multiple infusion/DME transactions in 2024-2025.